Shashidhar Nizalapur, Ph.D.

Group Lead (cmc-drug Substance/oligonucleotides/peptides) at PYC Therapeutics

Shashidhar Nizalapur, Ph.D. has extensive experience in synthetic organic and medicinal chemistry. Shashidhar has worked in various roles at companies like PYC Therapeutics, Syngene International Limited, and UNSW. Shashidhar has expertise in overseeing drug substance manufacturing, quality control implementation, and working with cross functional teams. Shashidhar also has a strong background in synthesis, purification, and characterization of various compounds for drug discovery projects. Additionally, Shashidhar has experience in teaching organic chemistry at a postgraduate level.

Links